---
title: "Ionis Pharmaceuticals (IONS) Receives a Buy from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295916358.md"
description: "Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals (IONS) with a $95 price target. This follows a Buy recommendation from J.P. Morgan's Jessica Fye on August 10, while Stifel Nicolaus had previously issued a Hold rating on August 2."
datetime: "2026-08-14T09:56:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295916358.md)
  - [en](https://longbridge.com/en/news/295916358.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295916358.md)
generator: "portal-rs"
---

# Ionis Pharmaceuticals (IONS) Receives a Buy from Wells Fargo

In a report released today, from Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals, with a price target of $95.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

In addition to Wells Fargo, Ionis Pharmaceuticals also received a Buy from J.P. Morgan’s Jessica Fye in a report issued on August 10. However, on August 2, Stifel Nicolaus maintained a Hold rating on Ionis Pharmaceuticals (NASDAQ: IONS).

### Related Stocks

- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [Great Lakes Advisors LLC Acquires Shares of 66,924 Ionis Pharmaceuticals, Inc. $IONS](https://longbridge.com/en/news/296455358.md)
- [How TRYNGOLZA Approval and New Equity Shelf At Ionis Pharmaceuticals (IONS) Has Changed Its Investment Story](https://longbridge.com/en/news/295401431.md)
- [Madrigal Pharma director John C. Reed files initial beneficial ownership statement](https://longbridge.com/en/news/296270622.md)
- [IONS Investors Have Opportunity to Join Ionis Pharmaceuticals, Inc. Fraud Investigation with SBS Law](https://longbridge.com/en/news/295307786.md)
- [Ionis Pharmaceuticals, Inc. $IONS Shares Acquired by California Public Employees Retirement System](https://longbridge.com/en/news/293717941.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**